These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1394 related articles for article (PubMed ID: 25407667)
1. Treatment of bipolar depression: making sensible decisions. Citrome L CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L; Ketter TA; Cucchiaro J; Loebel A J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116 [TBL] [Abstract][Full Text] [Related]
3. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Citrome L Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634 [TBL] [Abstract][Full Text] [Related]
4. Balancing benefits and harms of treatments for acute bipolar depression. Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Srivastava S; Ketter TA Clin Ther; 2011 Dec; 33(12):B40-8. PubMed ID: 22177379 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970 [TBL] [Abstract][Full Text] [Related]
7. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Taylor DM; Cornelius V; Smith L; Young AH Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of treatments for bipolar depression. Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634 [TBL] [Abstract][Full Text] [Related]
10. Olanzapine-fluoxetine combination for the treatment of bipolar depression. Citrome L Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291 [TBL] [Abstract][Full Text] [Related]
12. A review of FDA-approved treatment options in bipolar depression. McIntyre RS; Cha DS; Kim RD; Mansur RB CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder. Alamo C; López-Muñoz F; García-García P Expert Rev Neurother; 2014 Jun; 14(6):593-605. PubMed ID: 24779382 [TBL] [Abstract][Full Text] [Related]
14. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat. Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955 [TBL] [Abstract][Full Text] [Related]
15. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M; J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369 [TBL] [Abstract][Full Text] [Related]
18. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862 [TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. Adler CM; Fleck DE; Brecher M; Strakowski SM J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737 [TBL] [Abstract][Full Text] [Related]